Experts Question Equity Gaps in Healthcare AI
Healthcare leaders at a London summit warned that technology alone will not overcome barriers that keep underserved patients from benefiting from AI.
Updated on Nov. 10, 2026 in Healthcare
Live Poll
Do you trust new health technology will reach people in your community who need it?
At the Second Annual Economist AI in Health Summit 2026 in London, healthcare leaders questioned whether enough attention is paid to practical barriers preventing underserved patients from benefiting from healthcare AI. Experts warned that technological advances alone will not solve longstanding problems with access to medicines, healthcare infrastructure, and clinical services.
Why it matters
Pharmaceutical AI activity is concentrated on accelerating clinical trials and drug development rather than across the full medicines value chain. Speakers argued that without attention to access, the benefits of AI may reach only populations already well served by health systems.
Equity concerns were raised about two days into the summit discussions. Field research in Kenya and Tanzania found unreliable supplies, infrastructure limits, and difficulties ensuring patient follow-up.
The players
The Economist
The British weekly news and business publication that organized the AI in Health Summit series.
Access to Medicine Foundation
An Amsterdam-based nonprofit that tracks pharmaceutical companies' efforts to improve access to medicines in low- and middle-income countries.
European Patients' Forum
A Brussels-based network representing patient organizations across Europe, which conducted the 2025 survey on AI concerns.
The details
Participants noted that a 2025 European Patients' Forum survey raised concerns about transparency, lack of empathy, and inadequate patient representation in AI development. Healthcare datasets may underrepresent people who rarely access health services, and patients and communities are not currently shaping which problems AI is designed to address.
Timeline
2025: European Patients' Forum survey published raising AI concerns.
2026: Second Annual Economist AI in Health Summit held in London.
Health Landscape
The concerns echo findings from the 2025 European Patients' Forum survey, which flagged transparency, empathy, and patient representation in AI development. The summit discussion moves those worries toward the infrastructure and supply realities that determine who can actually use AI tools.
Patients in regions with limited medicine supply or clinic infrastructure may find AI-based screening tools unavailable or unreliable even when they are promoted. Those who rarely use health services may also be missing from the data that shapes future tools.
The takeaway
Access to AI in healthcare depends on supply chains, infrastructure, and follow-up care as much as on the technology itself. Patients and communities should be involved in deciding which problems AI addresses and how success is measured.
Further reading
For broader context on how AI is reshaping care delivery, explore the Healthcare section.
Source note: This article includes information reported by Medscape.
Live Poll
Do you trust new health technology will reach people in your community who need it?
